Saturday 17 October 2026
Export DHR’s income statement to Excel — free account
Danaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024. In the quarter to June 2026, revenue grew 5.54%, EPS grew 59.7%, free cash flow grew 15.6% and total debt rose 49.2%, each against the same quarter a year earlier. Member of the S&P 500.
228.97
2.53
−1.09%
Follow DHR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 7.63% | 7.11% | 7.08% | 6.84% |
+8 more TTM periods Free account |
|
Piotroski F-Score |
6 | 6 | 6 | 7 | |
| 4.60% | 4.54% | 4.49% | 4.36% | ||
ROIC |
4.37% | 4.59% | 4.42% | 4.34% | |
Return on Tangible Assets |
36.07% | 30.89% | 31.48% | 40.46% | |
Average Days of Receivables |
57.64 | 56.26 | 58.13 | 56.48 | |
Free Cash Flow per Share |
7.78 | 7.51 | 7.43 | 7.07 | |
Free Cash Flow |
5,489.00 | 5,318.00 | 5,293.00 | 5,028.00 | |
Capital Expenditures |
(1,146.00) | (1,121.00) | (1,123.00) | (1,290.00) | |
| Other line items | |||||
Cash ROIC |
6.69% | 6.98% | 7.00% | 7.24% | |
Accounts Receivable Turnover |
6.67 | 6.77 | 6.60 | 6.68 | |
Accounts Payable Turnover |
5.87 | 5.79 | 5.59 | 5.96 | |
Inventory Turnover |
3.50 | 3.96 | 4.17 | 3.67 | |
Average Days of Payables |
63.85 | 64.21 | 67.00 | 63.11 | |
Days of Inventory on Hand |
114.24 | 93.55 | 90.44 | 99.38 | |
Tax Rate |
(0.16) | (0.15) | (0.15) | (0.16) | |
Research and Development Expense of Revenue |
6.43% | 6.48% | 6.50% | 6.60% | |
Selling, General and Administrative Expense of Revenue |
31.66% | 33.24% | 33.52% | 33.92% | |
Share Based Compensation of Revenue |
1.18% | 1.19% | 1.21% | 1.20% | |
Interest Coverage |
17.56 | 18.59 | 17.70 | 17.02 | |
Operating CF/Net income |
1.66 | 1.75 | 1.78 | 1.80 | |
Depreciation/Fixed assets |
0.44 | 0.45 | 0.44 | 0.45 | |
Capex/Depreciation |
(0.44) | (0.45) | (0.46) | (0.53) | |
Revenue per Share |
35.60 | 35.00 | 34.47 | 34.15 | |
Operating CF per Share |
9.41 | 9.10 | 9.00 | 8.89 | |
Capex per Share |
(1.62) | (1.58) | (1.58) | (1.82) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.05 |
Columns are period end dates